MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
about
Mitochondrial vasculopathyMitochondrial cytochrome c oxidase deficiencyX-linked intellectual disability gene CASK regulates postnatal brain growth in a non-cell autonomous manner.Genetic susceptibility to cerebrovascular diseaseThe many faces of paediatric mitochondrial disease on neuroimaging.Mitochondrial pathology in progressive cerebellar ataxiaCyclic vomiting syndrome versus inborn errors of metabolism: A review with clinical recommendations.Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation.Mitochondrial cytopathy with common MELAS mutation presenting as multiple system atrophy mimic.Onset of MELAS due to the m.3243A > G mutation is early if the large phenotypic variability is considered.microRNA-mediated differential expression of TRMU, GTPBP3 and MTO1 in cell models of mitochondrial-DNA diseases.Epigenetic regulation of mitochondrial function in neurodegenerative disease: New insights from advances in genomic technologies.Secondary myopathy due to systemic diseases.Developmental window of sensorineural deafness in biotinidase-deficient mice.Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders.Genetics of mitochondrial dysfunction and infertility.Migratory stroke-like lesions in a case of adult-onset mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome and a review of imaging findings.Differential diagnosis of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) and ischemic stroke using 3D pseudocontinuous arterial spin labeling.Mitochondrial quality control: Cell-type-dependent responses to pathological mutant mitochondrial DNARecurrent Alternate-Sided Homonymous Hemianopia Due to Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-Like Episodes (MELAS): A Case Report.Mitochondrial Encephalomyopathy With Lactic Acidosis and Stroke-Like Episodes-MELAS Syndrome.Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.Inflexibility of AMPK-mediated metabolic reprogramming in mitochondrial disease.TRMT1-Catalyzed tRNA Modifications Are Required for Redox Homeostasis To Ensure Proper Cellular Proliferation and Oxidative Stress Survival.Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome.Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls.Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy.Late onset MELAS with m.3243A > G mutation and its association with aneurysm formation.MELAS and Kearns-Sayre overlap syndrome due to the mtDNA m. A3243G mutation and large-scale mtDNA deletions.Avascular necrosis after long-term glucocorticoid treatment in MELAS: a cautionary note.Hypoparathyroidism.Progressive External Ophthalmoplegia.Arginine and citrulline for the treatment of MELAS syndrome.Microvascular endothelial dysfunction in mitochondrial stroke-like episodes supports use of intravenous l-arginine.MELAS can be psychiatric and neurological.Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA MutationsMitochondrial disease: an uncommon but important cause of diabetes mellitusSerum expression levels of Mb and NT-proBNP and NF-κB expression in neutrophils in patients with MODS and the clinical significanceMitochondrial Genomics: A complex field now coming of age
P2860
Q26745617-9B15708C-5A31-47E0-9079-30CD1E69E032Q26769015-48583000-5F03-4914-890A-2F5232A9A0E2Q27317003-3DACD0E3-809C-42E0-9E1F-58618C348D60Q28076438-636F9B09-9E60-4540-A001-C89938A33746Q31116989-B855CD42-FE0F-4CD0-A1D4-102F94F523CAQ36348591-0FDB8802-B4CC-4021-8365-7DB4C26CB35CQ36506108-20AB16EB-F632-4ECF-9456-FAA7BA1E61F9Q36759443-D4E6BB9D-FF39-4E09-8367-4A3C488E8F9AQ37421984-5F80215A-9691-4634-9BCB-E0FC3E256D54Q37503608-F8991355-77B8-4450-9DCF-9BB5191311FEQ38663607-5AB70DCB-84FE-4275-BFFA-2099D209E3A3Q38733322-4C2AD75D-861B-44D1-BC50-8224E3B26222Q38750184-22C97DE4-D550-4E80-8EC8-E7BA9C57FB98Q38779537-75EA9B97-CFC0-4A4A-900D-1C8EA7BAE1C1Q38790569-11DA1FE8-00EB-4251-8B6E-CB38DC3609AFQ38982444-2052AFC2-7A43-4F82-AD16-FA37D67A7DFCQ39030218-F6D4F0F1-D110-48CF-813F-C10702767A9FQ39652188-110BF980-3F55-4698-B212-B2B8466F06CFQ40501815-B71DE29B-A2A7-48CA-BCDD-3EE33963DBB3Q41697800-3D1CA37C-CD53-4D13-A3B3-474EFB32D95DQ42283959-11460CC4-8835-4EC3-AD95-B61534C60B55Q43946370-F1915A99-82BC-4641-90E8-EBACA7C06988Q46050003-D190F987-B55A-42EF-B063-17A4C1E28164Q46324562-1D0C5363-E2BB-4C5A-A042-1D97D853B9F4Q47707444-086C8ABC-F3B8-4CA0-8B62-00985E3328CAQ47811763-1CDEA23D-15E8-4DF8-8B0F-D97F34DBC4C0Q48146997-F5A476C5-4C76-47AD-9C9E-199390AB12E8Q48254998-6617C3C3-E76C-408F-9EEA-8931EF5C1D53Q50072372-D9444553-DD78-4B27-91E7-9328A995D29CQ50129513-F7E33AD0-76BE-4252-A47D-1E8A26F0C084Q51799713-6AD68F8B-FCA5-4385-977E-0F57344322FBQ53924716-1FFCB601-9779-4099-B182-220E8A6EBFB7Q55036888-572ECB90-5CFE-49FB-9AD3-D1394F7779F4Q55115768-FDAE2FAB-A76A-44D5-80E0-77A5245F4358Q55249423-4D1CC261-1147-4D8E-BC81-7678AEC7A79EQ56384006-9ED1A4A2-9D0B-4167-99FB-A63BAE272E69Q57299920-51C13851-E910-476E-85BF-4E6554433409Q57786994-A3873720-8243-4BCD-A93D-9AC9F375DB33Q58573044-18412CC7-DAFC-4425-8526-1010AD48AD9A
P2860
MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
@en
type
label
MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
@en
prefLabel
MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
@en
P2093
P1476
MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
@en
P2093
Adekunle M Adesina
Ayman W El-Hattab
Fernando Scaglia
Jeremy Jones
P356
10.1016/J.YMGME.2015.06.004
P577
2015-06-15T00:00:00Z